April 26th 2024
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Investigating Real-world Consequences of Biases in Commonly Used Clinical Calculators
Clinical calculators that do not include demographic variables may be biased, and their equity should be understood in the context of clinical guidelines.
Read More
Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19
The Patient-Centered Rheumatology Collaborative identified several critical areas for further intervention to improve the delivery of high-quality, patient-centered care during the COVID-19 pandemic and beyond.
Read More
Patient Perspectives on Technology-Based Approaches to Social Needs Screening
Patients are essential stakeholders in designing systems to capture social needs. The authors present key findings from patient interviews regarding social needs screening through technology-based modalities.
Read More
Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care
Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.
Read More
Associations Between Physician Practice Models and Health Information Exchange
January 11th 2023A survey of all Arizona physicians found that accountable care organization, clinically integrated network, or integrated delivery network participation was associated with higher use of health information exchange. However, there are exceptions and important barriers noted.
Read More
Changes in Electronic Notification Volume and Primary Care Provider Burnout
Primary care provider burnout was analyzed before and after a national initiative to optimize the electronic health record inbox notification system at the Veterans Health Administration.
Read More
Limited Appointment Availability and Cost Largest Obstacles to Women’s Mental Health Care
January 5th 2023In the last 2 years, half of women reported needing mental health services compared with only 35% of men. Women who needed mental health care cited provider availability and cost, especially for those who are uninsured, to be 2 major barriers to receiving care.
Read More
Top 5 Most-Read Articles About Automated Insulin Delivery in 2022
December 20th 2022Content published on AJMC.com focusing on automated insulin delivery devices over the past year highlighted utilization of these devices by age, compared different types of systems, looked at barriers to uptake, and examined equity issues standing in the way of access.
Read More
Dr Kyle Lamb Discusses Transitional Care, Super-Utilization in Value-Based Medicine
December 19th 2022Kyle Lamb, MD, associate medical director of population health at Vancouver Clinic, discusses how super-utilization trends have changed since the start of COVID-19, the necessity of transitional care in implementing value-based medicine, and how technology can decrease super-utilization.
Watch
Telemedicine Care Quality, Social Vulnerability Index Barriers Measured for Patients With Epilepsy
December 12th 2022Abstracts from the American Epilepsy Society annual meeting show that telemedicine is capable of meeting the needs of patients with epilepsy, and that the patient portal accessibility for patients experiencing high social vulnerability index needs further research.
Read More
Dr Douglas Mann on Next Steps to Studying Gene Editing in Heart Failure
December 9th 2022Initial data on NTLA-2001, which is a novel investigative intravenous agent that works to prevent development of cardiac transthyretin (ATTR) amyloidosis by targeting the TTR gene and TTR protein levels, were presented at this year’s American Heart Association’s Scientific Sessions in Chicago.
Watch
Using Risk Factors to Guide CAR T Approach Before, After Infusion in B-ALL
December 8th 2022This paper follows the 10-year remission mark for the first child treated with CD19-targeted CAR (chimeric antigen receptor) T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL), adding promise to the notion that the technology can provide long-term durable remissions in patients who are highly refractory to chemotherapy.
Read More